We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are ...
UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to ...
1d
Zacks Investment Research on MSNUnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth KnowingIn the latest trading session, UnitedHealth Group (UNH) closed at $516.85, marking a +1.09% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.08% for the day.
(Reuters) -UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get ...
A UnitedHealth Group Inc. subsidiary won court approval of a $20.25 million settlement with the US Labor Department over ...
UnitedHealth Group’s pharmacy benefit manager OptumRx plans to cut up to 25% of its medication reauthorizations. OptumRx will ...
UnitedHealth Group Inc.’s pharmacy benefit manager, Optum Rx, will ease renewal requirements for certain long-term ...
Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) have been assigned an average rating of “Buy” from the ...
(KFF) – The Justice Department’s years-long court battle to force UnitedHealth Group to return billions of dollars in alleged Medicare Advantage overpayments hit a major setback Monday when a special ...
There have been heightened security concerns since the shooting of CEO Brian Thompson, and an online threat to the company's ...
11d
Zacks.com on MSNUnitedHealth Group (UNH) Gains As Market Dips: What You Should KnowIn the latest trading session, UnitedHealth Group (UNH) closed at $486.04, marking a +1.21% move from the previous day.
UnitedHealth Group ( NYSE: UNH) announced Wednesday its pharmacy benefit manager, Optum Rx, would eliminate up to 25% of reauthorizations, easing patients’ access to multiple medications when their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results